tradingkey.logo

Equillium Announces Up To $50 Million Financing To Advance EQ504, A Novel Aryl Hydrocarbon Receptor Modulator, Into The Clinic

ReutersAug 11, 2025 12:57 PM

- Equillium Inc EQ.O:

  • EQUILLIUM ANNOUNCES UP TO $50 MILLION FINANCING TO ADVANCE EQ504, A NOVEL ARYL HYDROCARBON RECEPTOR MODULATOR, INTO THE CLINIC

  • EQUILLIUM INC - PHASE 1 STUDY INITIATION PLANNED MID-2026, DATA EXPECTED 6 MONTHS LATER

  • EQUILLIUM INC - EXPECTS CASH RUNWAY EXTENSION THROUGH 2027

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI